Search

Your search keyword '"Bonilla, G."' showing total 47 results

Search Constraints

Start Over You searched for: Author "Bonilla, G." Remove constraint Author: "Bonilla, G." Publisher bmj Remove constraint Publisher: bmj
47 results on '"Bonilla, G."'

Search Results

1. AB0416 SUBCUTANEUS VS INTRAVENOUS ABATACEPT IN RHEUMATOID ARTHRITIS-INTERSTITIAL LUNG DISEASE. NATIONAL MULTICENTER STUDY OF 392 PATIENTS

2. AB0594 CLINICAL SIGNIFICANCE OF ANTI-LA ANTIBODIES IN SYSTEMIC LUPUS ERYTHEMATOSUS

3. POS1427 CLINICAL COURSE IN PATIENTS WITH INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES (IPAF): REAL-LIFE DATA FROM A MULTICENTER ILD REGISTRY

5. AB0376 DIFFERENCES IN IMMUNOGLOBULIN LEVELS IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS AND RHEUMATOID ARTHRITIS TREATED WITH RITUXIMAB

6. POS0623 CYTOKINE PRODUCTION BY BLOOD LYMPHOCYTES DEFINES A PROFILE ASSOCIATED WITH NON-REMISSION IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TNF INHIBITORS

7. POS1260 FACTORS ASSOCIATED WITH SEVERE SARS-COV-2 INFECTION IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES IN MADRID: RESULTS FROM REUMA-COVID SORCOM REGISTRY

8. POS0721 ARE ANTIMALARIALS SAFE FOR THE HEART OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS? ANALYSIS OF FACTORS ASSOCIATED WITH THE DEVELOPMENT OF HEART FAILURE IN PATIENTS IN THE SPANISH SOCIETY OF RHEUMATOLOGY LUPUS REGISTRY (RELESSER)

9. SAT0075 ABATACEPT IN COMBINATION WITH METOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS ASSOCIATED TO INTERSTITIAL LUNG DISEASE: NATIONAL MULTICENTER STUDY OF 263 PATIENTS

10. SAT0035 RESPONSE TO ABATACEPT OF DIFFERENT PATTERNS OF INTERSTITIAL LUNG DISEASE IN RHEUMATOID ARTHRITIS: NATIONAL MULTICENTER STUDY OF 263 PATIENTS

11. FRI0582 GM-CSF PRODUCED BY CD4+ T CELLS AS A MARKER OF CLINICAL REMISSION IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TNF INHIBITORS

14. OP0002 INCIDENCE OF FIRST CARDIOVASCULAR EVENT IN SPANISH PATIENTS WITH CHRONIC INFLAMMATORY RHEUMATIC DISEASES: PROSPECTIVE DATA FROM THE CARMA PROJECT AFTER 5 YEARS OF FOLLOW-UP

16. OP0212 ABATACEPT IN INTERSTITIAL LUNG DISEASE ASSOCIATED WITH RHEUMATOID ARTHRITIS. NATIONAL MULTICENTER STUDY OF 263 PATIENTS

17. FRI0294 MUSCULOSKELETAL MANIFESTATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB

18. AB0302 Influence of Tapering Biological Therapies in Immunogenicity in A Cohort of Rheumatoid Arthritis with Low Disease Activity

19. AB0660 Predictors of Flare after Tapering Anti-TNF Therapy in Patients with Axial Spondyloarthritis

20. AB0305 Influence of Drug Levels during The First Anti-Tnf Therapy on The Clinical Response To A Second Biologic in Rheumatoid Arthritis Patients

25. FRI0405 Extraarticular Manifestations in Patients with Spondyloarthritis under Biologic Treatment

27. THU0206 Influence of the Tapering Strategy TNF Inhibitors on the Immunogenicity in a Cohort of Spondyloarthritis Patients in Low Disease Activity

28. SAT0402 Damage and Mortality in SLE: Cluster Analysis of Patients from SLE Registry from the Spanish Society of Rheumatology (Relesser)

30. FRI0106 Influence of Optimization of Biological Therapies on Immunogenicity in a Cohort of Rheumatoid Arthritis with Low Disease Activity

37. FRI0168 Etanercept serum trough levels are correlated with clinical activity in rheumatoid arthritis patients with long-term treatment with etanercept

38. AB0573 The immunogenicity of biological therapies correlates with clinical efficacy in psoriatic arthritis (psa) in long-term treatment with infliximab and adalimumab.

39. FRI0321 Efficiency of interferon-Γ release assay for screening for latent tuberculosis in patients with systemic lupus erythematosus

40. SAT0209 Characterization of pure membranous lupus nephritis: A cohort of 134 patients

42. Damage in a large systemic lupus erythematosus cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER) with emphasis on the cardiovascular system: a longitudinal analysis.

43. SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort.

44. Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases.

45. Influence of immunogenicity on the efficacy of longterm treatment of spondyloarthritis with infliximab.

46. A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects.

47. Assessment of inflammatory activity in rheumatoid arthritis: a comparative study of clinical evaluation with grey scale and power Doppler ultrasonography.

Catalog

Books, media, physical & digital resources